FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2349-2352 June 5, 2003 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Perkins, B. A. Related Article by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group PubMed Citation

Diabetes mellitus causes a dramatic increase in mortality, particularly from cardiovascular causes: the survival rate among persons with either type 1 or type 2 diabetes and no history of coronary heart disease was reported to be as poor as that of survivors of myocardial infarction.¹ Although accounting for only approximately 10 percent of all cases of diabetes, type 1 diabetes has been investigated far more completely than other forms. Trials concerning the importance of glycemic control^2,3 or the response of nephropathy to intervention with antihypertensive agents^4,5 have shown, however, that with certain limitations, the results of interventional studies of type . . . [Full Text of this Article]

Source Information

From the University of Heidelberg, Heidelberg, Germany.

Related Letters:

Regression of Microalbuminuria in Type 1 Diabetes
Friedman A. N., Catena C., Novello M., Sechi L. A., Hohenadel D., Bode H., van der Woude F. J., Zerbini G., Perkins B. A., Warram J. H., Krolewski A. S.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:906-908, Aug 28, 2003. Correspondence

This article has been cited by other articles:

• Nguyen, S., McCulloch, C., Brakeman, P., Portale, A., Hsu, C.-y. (2008). Being Overweight Modifies the Association Between Cardiovascular Risk Factors and Microalbuminuria in Adolescents. Pediatrics 121: 37-45 [Abstract] [Full Text]  
• Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., Krolewski, A. S. (2007). Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes. J. Am. Soc. Nephrol. 18: 1353-1361 [Abstract] [Full Text]  
• Pietroiusti, A., Giuliano, M., Magrini, A., Bergamaschi, A., Galante, A. (2006). Cytotoxin-Associated Gene A Strains of Helicobacter Pylori Represent a Risk Factor for the Development of Microalbuminuria in Type 2 Diabetes.. Diabetes Care 29: 1399-1401 [Full Text]  
• De, P., Das, G., Harley, K., Nair, H. (2006). Review: Dual blockade of renin-angiotensin system in diabetic nephropathy: review of literature and local experience. British Journal of Diabetes & Vascular Disease 6: 23-28 [Abstract]  
• Wu, T.-L., Chang, P.-Y., Li, C.-C., Tsao, K.-C., Sun, C.-F., Wu, J. T. (2005). Microplate ELISA for Urine Microalbumin: Reference Values and Results in Patients with Type 2 Diabetes and Cardiovascular Disease. Annals of Clinical & Laboratory Science 35: 149-154 [Abstract] [Full Text]  
• Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., Ene-Iordache, B., Gaspari, F., Perna, A., Bossi, A., Trevisan, R., Dodesini, A. R., Remuzzi, G., the Bergamo Nephrologic Diabetes Complications Tri, (2004). Preventing Microalbuminuria in Type 2 Diabetes. NEJM 351: 1941-1951 [Abstract] [Full Text]  
• Butler, D. A., Lawlor, M. T. (2004). It Takes a Village: Helping Families Live With Diabetes. Diabetes Spectr. 17: 26-31 [Abstract] [Full Text]  
• Friedman, A. N., Catena, C., Novello, M., Sechi, L. A., Hohenadel, D., Bode, H., van der Woude, F. J., Zerbini, G., Perkins, B. A., Warram, J. H., Krolewski, A. S. (2003). Regression of Microalbuminuria in Type 1 Diabetes. NEJM 349: 906-908 [Full Text]